Shine-On BioMedical Co (ROCO:6926) Retained Earnings: NT$-410.39 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6926 Shine-On BioMedical Co Ltd ROCO:6926
12 GF Score
Price NT$63.00
! 1 Warning Sign
View Full Analysis

What is Shine-On BioMedical Co Retained Earnings?

Shine-On BioMedical Co ROCO:6926 12 Retained Earnings is NT$-410.39 Mil as of Jun. 2026. GuruFocus rates ROCO:6926 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Shine-On BioMedical Co's retained earnings for the quarter that ended in Jun. 2026 was NT$-410.39 Mil.

Shine-On BioMedical Co's quarterly retained earnings declined from Jun. 2025 (NT$-228.67 Mil) to Dec. 2025 (NT$-294.32 Mil) and declined from Dec. 2025 (NT$-294.32 Mil) to Jun. 2026 (NT$-410.39 Mil).

Shine-On BioMedical Co's annual retained earnings declined from Dec. 2023 (NT$-65.14 Mil) to Dec. 2024 (NT$-184.03 Mil) and declined from Dec. 2024 (NT$-184.03 Mil) to Dec. 2025 (NT$-294.32 Mil).


Shine-On BioMedical Co  (ROCO:6926) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Shine-On BioMedical Co Retained Earnings Historical Data

* Premium members only.

The historical data trend for Shine-On BioMedical Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shine-On BioMedical Co Retained Earnings Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial -8.43 -27.98 -65.14 -184.03 -294.32

Shine-On BioMedical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -111.60 -184.03 -228.67 -294.32 -410.39
ROCO:6926
12GF Score
Shine-On BioMedical Co Ltd ROCO:6926
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shine-On BioMedical Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of NT$-410.39 Mil mean?
Shine-On BioMedical Co (ROCO:6926) has a Retained Earnings of NT$-410.39 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Shine-On BioMedical Co and its competitors.
Is Shine-On BioMedical Co's Retained Earnings too high?
Shine-On BioMedical Co's current Retained Earnings is NT$-410.39 Mil. Overall, Shine-On BioMedical Co has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Shine-On BioMedical Co's Retained Earnings compare to VRTX and REGN?
Shine-On BioMedical Co's Retained Earnings of NT$-410.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Shine-On BioMedical Co and its competitors. Shine-On BioMedical Co's current Retained Earnings is NT$-410.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shine-On BioMedical Co stock overvalued right now?
Shine-On BioMedical Co (ROCO:6926) has a current Retained Earnings of NT$-410.39 Mil. The current Retained Earnings is NT$-410.39 Mil. Shine-On BioMedical Co's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Shine-On BioMedical Co (ROCO:6926), the current Retained Earnings is NT$-410.39 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shine-On BioMedical Co Business Description

Address No. 573, Taiwan Boulevard, 10th Floor, Section 2, West District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with effective cancer treatment options.
12GF Score

Get the complete analysis for ROCO:6926

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.00
Price